Jessica A. Pollard

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing et al. · Blood · 2009 · 216 citations · Full text

Medicine, Oncology, Pediatrics +12

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing et al. · Blood · 2010 · 183 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

Richard Aplenc, Soheil Meshinchi, Lillian Sung et al. · Haematologica · 2020 · 169 citations · Full text

Medicine, Hematology, Oncology +17

Suggestion Reduces the Stroop Effect

Amir Raz, Irving Kirsch, Jessica A. Pollard et al. · Psychological Science · 2006 · 161 citations

Social Sciences, Behavioral Sciences, Psychology +9

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children’s Oncology Group Trial AAML0531

Jatinder K. Lamba, Lata Chauhan, Miyoung Shin et al. · Journal of Clinical Oncology · 2017 · 151 citations

Medicine, Hematology, Oncology +17